These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Single-Cell Analysis of Different Stages of Oral Cancer Carcinogenesis in a Mouse Model. Huang LY; Hsieh YP; Wang YY; Hwang DY; Jiang SS; Huang WT; Chiang WF; Liu KJ; Huang TT Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142921 [TBL] [Abstract][Full Text] [Related]
5. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC. Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083 [TBL] [Abstract][Full Text] [Related]
6. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis. Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610 [TBL] [Abstract][Full Text] [Related]
7. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma. Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316 [TBL] [Abstract][Full Text] [Related]
8. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling. Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity. Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry profile of p75 neurotrophin receptor in oral epithelial dysplasia and oral squamous cell carcinoma induced by 4-nitroquinoline 1-oxide in rats. Teixeira Buck MG; Souza Cabral Tuci P; Perillo Rosin FC; Pinheiro Barcessat AR; Corrêa L Arch Oral Biol; 2018 Dec; 96():169-177. PubMed ID: 30268558 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide. Peng X; Li W; Johnson WD; Torres KE; McCormick DL PLoS One; 2015; 10(1):e0116285. PubMed ID: 25635769 [TBL] [Abstract][Full Text] [Related]
13. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432 [TBL] [Abstract][Full Text] [Related]
14. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma. Mohajertehran F; Sahebkar A; Zare R; Mohtasham N J Cell Physiol; 2018 Nov; 233(11):8499-8507. PubMed ID: 29797575 [TBL] [Abstract][Full Text] [Related]
15. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Tang XH; Albert M; Scognamiglio T; Gudas LJ Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362 [TBL] [Abstract][Full Text] [Related]
16. 4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development. Sahu SR; Thakur S; Peroumal D; Utkalaja BG; Dutta A; Kumari P; Subhadarsini I; Acharya N Front Immunol; 2023; 14():1274519. PubMed ID: 37936711 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. Nomura H; Uzawa K; Ishigami T; Kouzu Y; Koike H; Ogawara K; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H BMC Cancer; 2008 Feb; 8():39. PubMed ID: 18237446 [TBL] [Abstract][Full Text] [Related]
18. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline. Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511 [TBL] [Abstract][Full Text] [Related]
19. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Hawkins BL; Heniford BW; Ackermann DM; Leonberger M; Martinez SA; Hendler FJ Head Neck; 1994; 16(5):424-32. PubMed ID: 7960739 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Leeman-Neill RJ; Seethala RR; Singh SV; Freilino ML; Bednash JS; Thomas SM; Panahandeh MC; Gooding WE; Joyce SC; Lingen MW; Neill DB; Grandis JR Cancer Prev Res (Phila); 2011 Feb; 4(2):230-7. PubMed ID: 21163936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]